Logo image of NDX1.DE

NORDEX SE (NDX1.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:NDX1 - DE000A0D6554 - Common Stock

28.82 EUR
-0.4 (-1.37%)
Last: 12/23/2025, 7:00:00 PM
Fundamental Rating

4

Taking everything into account, NDX1 scores 4 out of 10 in our fundamental rating. NDX1 was compared to 69 industry peers in the Electrical Equipment industry. The financial health of NDX1 is average, but there are quite some concerns on its profitability. NDX1 has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year NDX1 was profitable.
In the past year NDX1 had a positive cash flow from operations.
In the past 5 years NDX1 reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: NDX1 reported negative operating cash flow in multiple years.
NDX1.DE Yearly Net Income VS EBIT VS OCF VS FCFNDX1.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M

1.2 Ratios

NDX1 has a Return On Assets of 1.84%. This is comparable to the rest of the industry: NDX1 outperforms 53.62% of its industry peers.
NDX1 has a Return On Equity (10.10%) which is in line with its industry peers.
NDX1 has a Return On Invested Capital of 5.51%. This is comparable to the rest of the industry: NDX1 outperforms 52.17% of its industry peers.
Industry RankSector Rank
ROA 1.84%
ROE 10.1%
ROIC 5.51%
ROA(3y)-5.3%
ROA(5y)-4.89%
ROE(3y)-28.94%
ROE(5y)-25.05%
ROIC(3y)N/A
ROIC(5y)N/A
NDX1.DE Yearly ROA, ROE, ROICNDX1.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40

1.3 Margins

The Profit Margin of NDX1 (1.50%) is comparable to the rest of the industry.
NDX1 has a Operating Margin of 4.14%. This is comparable to the rest of the industry: NDX1 outperforms 50.72% of its industry peers.
NDX1's Operating Margin has improved in the last couple of years.
NDX1 has a worse Gross Margin (14.32%) than 81.16% of its industry peers.
NDX1's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 4.14%
PM (TTM) 1.5%
GM 14.32%
OM growth 3YN/A
OM growth 5Y57.84%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y19.47%
GM growth 5Y-2.61%
NDX1.DE Yearly Profit, Operating, Gross MarginsNDX1.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), NDX1 is destroying value.
The number of shares outstanding for NDX1 remains at a similar level compared to 1 year ago.
Compared to 5 years ago, NDX1 has more shares outstanding
The debt/assets ratio for NDX1 is higher compared to a year ago.
NDX1.DE Yearly Shares OutstandingNDX1.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
NDX1.DE Yearly Total Debt VS Total AssetsNDX1.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

NDX1 has an Altman-Z score of 2.24. This is not the best score and indicates that NDX1 is in the grey zone with still only limited risk for bankruptcy at the moment.
NDX1 has a Altman-Z score (2.24) which is comparable to the rest of the industry.
NDX1 has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.06
Altman-Z 2.24
ROIC/WACC0.69
WACC7.95%
NDX1.DE Yearly LT Debt VS Equity VS FCFNDX1.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B

2.3 Liquidity

A Current Ratio of 1.04 indicates that NDX1 should not have too much problems paying its short term obligations.
With a Current ratio value of 1.04, NDX1 is not doing good in the industry: 73.91% of the companies in the same industry are doing better.
NDX1 has a Quick Ratio of 1.04. This is a bad value and indicates that NDX1 is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of NDX1 (0.77) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.04
Quick Ratio 0.77
NDX1.DE Yearly Current Assets VS Current LiabilitesNDX1.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

5

3. Growth

3.1 Past

NDX1 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 360.00%, which is quite impressive.
NDX1 shows a small growth in Revenue. In the last year, the Revenue has grown by 1.27%.
The Revenue has been growing by 17.32% on average over the past years. This is quite good.
EPS 1Y (TTM)360%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%2100%
Revenue 1Y (TTM)1.27%
Revenue growth 3Y10.27%
Revenue growth 5Y17.32%
Sales Q2Q%2.09%

3.2 Future

NDX1 is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 163.17% yearly.
Based on estimates for the next years, NDX1 will show a small growth in Revenue. The Revenue will grow by 5.78% on average per year.
EPS Next Y2415.58%
EPS Next 2Y468.92%
EPS Next 3Y235.02%
EPS Next 5Y163.17%
Revenue Next Year2.56%
Revenue Next 2Y5.84%
Revenue Next 3Y5.69%
Revenue Next 5Y5.78%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
NDX1.DE Yearly Revenue VS EstimatesNDX1.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B 8B 10B
NDX1.DE Yearly EPS VS EstimatesNDX1.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 -1 -2

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 62.65, NDX1 can be considered very expensive at the moment.
NDX1's Price/Earnings ratio is in line with the industry average.
NDX1 is valuated expensively when we compare the Price/Earnings ratio to 26.59, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 22.26, the valuation of NDX1 can be described as rather expensive.
Based on the Price/Forward Earnings ratio, NDX1 is valued a bit cheaper than 63.77% of the companies in the same industry.
NDX1 is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 24.03, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 62.65
Fwd PE 22.26
NDX1.DE Price Earnings VS Forward Price EarningsNDX1.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

76.81% of the companies in the same industry are more expensive than NDX1, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, NDX1 is valued cheaply inside the industry as 84.06% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 12.36
EV/EBITDA 11.27
NDX1.DE Per share dataNDX1.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as NDX1's earnings are expected to grow with 235.02% in the coming years.
PEG (NY)0.03
PEG (5Y)N/A
EPS Next 2Y468.92%
EPS Next 3Y235.02%

0

5. Dividend

5.1 Amount

No dividends for NDX1!.
Industry RankSector Rank
Dividend Yield 0%

NORDEX SE

FRA:NDX1 (12/23/2025, 7:00:00 PM)

28.82

-0.4 (-1.37%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)11-04 2025-11-04/bmo
Earnings (Next)02-25 2026-02-25
Inst Owners35.3%
Inst Owner ChangeN/A
Ins Owners2.96%
Ins Owner ChangeN/A
Market Cap6.81B
Revenue(TTM)7.21B
Net Income(TTM)108.12M
Analysts80
Price Target28.19 (-2.19%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.27%
Min EPS beat(2)4.47%
Max EPS beat(2)6.08%
EPS beat(4)3
Avg EPS beat(4)6.89%
Min EPS beat(4)-48.1%
Max EPS beat(4)65.12%
EPS beat(8)6
Avg EPS beat(8)75.54%
EPS beat(12)6
Avg EPS beat(12)-6.9%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-5.03%
Min Revenue beat(2)-12.49%
Max Revenue beat(2)2.43%
Revenue beat(4)1
Avg Revenue beat(4)-9.82%
Min Revenue beat(4)-14.66%
Max Revenue beat(4)2.43%
Revenue beat(8)4
Avg Revenue beat(8)-1.76%
Revenue beat(12)8
Avg Revenue beat(12)2.89%
Revenue beat(16)10
Avg Revenue beat(16)1.29%
PT rev (1m)14.15%
PT rev (3m)21.14%
EPS NQ rev (1m)-4.44%
EPS NQ rev (3m)82.01%
EPS NY rev (1m)16.64%
EPS NY rev (3m)41.25%
Revenue NQ rev (1m)-0.88%
Revenue NQ rev (3m)-0.52%
Revenue NY rev (1m)-1.17%
Revenue NY rev (3m)-2.69%
Valuation
Industry RankSector Rank
PE 62.65
Fwd PE 22.26
P/S 0.95
P/FCF 12.36
P/OCF 9.7
P/B 6.37
P/tB 21.66
EV/EBITDA 11.27
EPS(TTM)0.46
EY1.6%
EPS(NY)1.29
Fwd EY4.49%
FCF(TTM)2.33
FCFY8.09%
OCF(TTM)2.97
OCFY10.31%
SpS30.48
BVpS4.53
TBVpS1.33
PEG (NY)0.03
PEG (5Y)N/A
Graham Number6.84
Profitability
Industry RankSector Rank
ROA 1.84%
ROE 10.1%
ROCE 13.49%
ROIC 5.51%
ROICexc 15.8%
ROICexgc 774.62%
OM 4.14%
PM (TTM) 1.5%
GM 14.32%
FCFM 7.65%
ROA(3y)-5.3%
ROA(5y)-4.89%
ROE(3y)-28.94%
ROE(5y)-25.05%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y149.59%
ROICexc growth 3YN/A
ROICexc growth 5Y97.25%
OM growth 3YN/A
OM growth 5Y57.84%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y19.47%
GM growth 5Y-2.61%
F-Score7
Asset Turnover1.22
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.06
Debt/EBITDA 0
Cap/Depr 86.34%
Cap/Sales 2.1%
Interest Coverage 3.19
Cash Conversion 148.27%
Profit Quality 510.01%
Current Ratio 1.04
Quick Ratio 0.77
Altman-Z 2.24
F-Score7
WACC7.95%
ROIC/WACC0.69
Cap/Depr(3y)91.26%
Cap/Depr(5y)96.94%
Cap/Sales(3y)2.63%
Cap/Sales(5y)2.91%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)360%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%2100%
EPS Next Y2415.58%
EPS Next 2Y468.92%
EPS Next 3Y235.02%
EPS Next 5Y163.17%
Revenue 1Y (TTM)1.27%
Revenue growth 3Y10.27%
Revenue growth 5Y17.32%
Sales Q2Q%2.09%
Revenue Next Year2.56%
Revenue Next 2Y5.84%
Revenue Next 3Y5.69%
Revenue Next 5Y5.78%
EBIT growth 1Y57.02%
EBIT growth 3YN/A
EBIT growth 5Y85.18%
EBIT Next Year524.93%
EBIT Next 3Y99.07%
EBIT Next 5Y53.94%
FCF growth 1Y259.7%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y487.28%
OCF growth 3Y49.91%
OCF growth 5Y62.45%

NORDEX SE / NDX1.DE FAQ

Can you provide the ChartMill fundamental rating for NORDEX SE?

ChartMill assigns a fundamental rating of 4 / 10 to NDX1.DE.


What is the valuation status for NDX1 stock?

ChartMill assigns a valuation rating of 5 / 10 to NORDEX SE (NDX1.DE). This can be considered as Fairly Valued.


Can you provide the profitability details for NORDEX SE?

NORDEX SE (NDX1.DE) has a profitability rating of 3 / 10.


How financially healthy is NORDEX SE?

The financial health rating of NORDEX SE (NDX1.DE) is 5 / 10.


Can you provide the expected EPS growth for NDX1 stock?

The Earnings per Share (EPS) of NORDEX SE (NDX1.DE) is expected to grow by 2415.58% in the next year.